You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. DEVELOPMENT OF A LOW COST ETHYLENE OXIDE DETECTOR

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    THE OBJECTIVE OF THIS RESEARCH PROGRAM IS TO DEMONSTRATE THE FEASIBILITY AND DEVELOP TOWARDS COMMERCIALIZATION A LOW-COST, RELIABLE DETECTOR TO MONITOR ETHYLENE OXIDE (ETO) DOWN TO THE 0.1 PPM LEVEL. THE DETECTOR WOULD HAVE A RESPONSE TIME OF ONE MINUTE OR LESS AND WOULD FEATURE A GAS CHROMATOGRAPH (GC) COLUMN COUPLED WITH A SOLID STATE COMBUSTIBLE GAS SENSOR. AIR DRAWN AS PART OF THE SAMPLE WOULD ...

    SBIR Phase II 1990 Department of Health and Human Services
  2. DEVELOPMENT OF A LOW-COST ETHYLENE OXIDE DETECTOR

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    N/A

    SBIR Phase II 1990 Department of Health and Human Services
  3. CHROMIUM DEFICIENCY IN INSULIN RESISTANCE

    SBC: ATOM SCIENCES, INC.            Topic: N/A

    CHROMIUM DEFICIENCY CAUSES SEVERE INSULIN RESISTANCE AND GLUCOSE INTOLERANCE. AVERAGE DIETARY CHROMIUM INTAKE IN THEUNITED STATES AND OTHER DEVELOPED COUNTRIES IS MARGINAL AND MAY CONTRIBUTE TO THE HIGH FREQUENCY OF DIABETES PLAGUING DEVELOPED COUNTRIES. THE MAJOR CLINICAL CHROMIUM EVALUATIONPROBLEM IS THE ASSESSMENT OF CHROMIUM STATUS. DETERMINATIONOF CHROMIUM STATUS HAS BEEN DIFFICULT BECAUSE OF ...

    SBIR Phase II 1990 Department of Health and Human Services
  4. A BIODEGRADABLE, INJECTABLE DELIVERY SYSTEM FOR NSAIDS

    SBC: ATRIX LABORATORIES, INC.            Topic: N/A

    IN THIS RESEARCH, NSAIDS WILL BE INDIVIDUALLY INCORPORATED INTO A DELIVERY SYSTEM. THE IN VITRO DELIVERY RATES WILL BEDETERMINED, AND THEN THE SYSTEM OPTIMIZED TO OBTAIN IN VITRO DELIVERY RATES OF 1 TO 12 WEEKS. THE VARIABLES THAT WILL BE EXAMINED TO OPTIMIZE RELEASE ARE POLYMER TYPE AND MOLECULAR WEIGHT, DRUG LOADING, AND BIOCOMPATIBLE PLASTICIZER CONTENT. FIVE NSAIDS WILL BE INDIVIDUALLY EVALUAT ...

    SBIR Phase I 1990 Department of Health and Human Services
  5. N/A

    SBC: ATRIX LABORATORIES, INC.            Topic: N/A

    N/A

    SBIR Phase I 1990 Department of Health and Human Services
  6. FULL-LENGTH, FIBEROPTIC ESOPHAGEAL PRESSURE MONITOR

    SBC: Begej Corp.            Topic: N/A

    THE OVERALL GOAL OF THIS PROJECT IS TO DEVELOP AN INNOVATIVE, FULL-LENGTH, FIBEROPTIC ESOPHAGEAL PRESSURE-MONITORING INSTRUMENT. THIS DEVICE WILL CONTRIBUTETO IMPROVED HEALTH CARE BY OFFERING SIGNIFICANTLY ENHANCED PERFORMANCE AND LOWER COST OVER CURRENT METHODS OF CHARACTERIZING PATHOLOGICAL BEHAVIOR OF THE ESOPHAGUS AND RELATED ORGANS. THE IMMEDIATE GOALS OF THE PHASE I PROJECT ARE TO DEMONSTRAT ...

    SBIR Phase I 1990 Department of Health and Human Services
  7. OPTICAL ASSAY FOR MEASURING COLLAGENASE IN GCF

    SBC: Biostar Medical Products, Inc            Topic: N/A

    THIS PROJECT WILL DEVELOP A RAPID ASSAY FOR MEASURING COLLAGENASE ACTIVITY IN GINGIVAL CREVICULAR FLUID (GCF) TO DIAGNOSE PERIODONTAL DISEASE, WHICH IS VERY PREVALENT IN THE U.S. POPULATION, AFFECTING UP TO 75 PERCENT OF ADULTS. MOST DIAGNOSTIC TECHNIQUES AVAILABLE TO CLINICIANS CANNOT PREDICT FUTURE ATTACHMENT LOSS. COLLAGENASE IN GCF IS AN IMPORTANT MARKER OF DISEASE ACTIVITY, BUT PREVIOUS METHO ...

    SBIR Phase I 1990 Department of Health and Human Services
  8. DEVELOPMENT OF A QUANTITATIVE ANTIBODY BINDING KIT

    SBC: CARIBBEAN MICROPARTICLES CORP.            Topic: N/A

    THE DIAGNOSIS OF A VARIETY OF DISEASES (E.G., LEUKEMIA AND AIDS) CAN BE FACILITATED BY STUDYING THE VARIOUS SUB-POPULATIONS OF LEUKOCYTES IN THE BLOOD. ALTHOUGH MONOCLONAL ANTIBODIES HAVE BEEN USED SUCCESSFULLY TO QUALITATIVELY CHARACTERIZE MANY PATHOLOGICAL DISEASES, IT REMAINS EXTREMELY DIFFICULT TO QUANTITATE MONOCLONAL ANTIBODY BINDING SITES ON A PARTICULAR CELL TYPE. CHANGES IN THE NUMBER OF ...

    SBIR Phase II 1990 Department of Health and Human Services
  9. REACTIVE OXYGEN SPECIES AND ULTRAVIOLET LIGHT DAMAGE

    SBC: Chemex Pharmaceuticals Inc            Topic: N/A

    CHEMEX PHARMACEUTICALS, INC.'S, NORDIHYDROGUAIARETIC ACID (CHX 100) IS A POTENT ANTIOXIDANT ALSO POSSESSING ANTIPROLIFERATIVE, ANTITUMOR, AND LIPOXYGENASE INHIBITION ACTIVITIES. THESE ACTIONS, ESPECIALLY ITS ANTIOXIDANT AND LIPOXYGENASE INHIBITORY ACTIVITIES, SUGGEST THAT CHX 100 MAY REDUCE THE DELETERIOUS EFFECTS OF ACUTE ULTRAVIOLET LIGHT (UVL) EXPOSURE ON THE SKIN, AS THESE EFFECTS MAY BE ASSOC ...

    SBIR Phase I 1990 Department of Health and Human Services
  10. PREDICTION AND DISPLAY OF INTERACTIONS OF MACROMOLECULES

    SBC: Consultec Scientific            Topic: N/A

    N/A

    SBIR Phase I 1990 Department of Health and Human Services
US Flag An Official Website of the United States Government